Phase II prospective open label study of neoadjuvant pertuzumab, trastuzumab, and nab-paclitaxel in patients with HER-2 positive advanced breast cancer.Sayeh Moazami Lavasani,Susan Elaine Yost,Paul Henry Frankel,Christopher Ruel,Mireya Murga, Aileen Tang,Norma Martinez,Laura Kruper, Lusine Tumyan,Dan Schmolze,Francesca Menghi,Edison T. Liu,Christina Haeyoung Yeon,Yuan Yuan, James Ross Waisman,George Somlo,Joanne E. MortimerJOURNAL OF CLINICAL ONCOLOGY（2021）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
